Clair J. Beard, MD

Publications

Nguyen PL, Chen MH, Goldhaber SZ, Martin NE, Beard CJ, Dosoretz DE, Katin MJ, Ross R, Salenius SA, D'Amico AV.Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation
21108457
Nguyen PL, Chen MH, Beard CJ, Suh WW, Renshaw AA, Loffredo M, McMahon E, Kantoff PW, D'Amico AV.Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate- and High-Risk Clinically Localized Prostate Cancer: A Postrandomization
19864082
Nguyen PL, Chen MH, Choueiri TK, Hoffman KE, Hu JC, Martin NE, Beard CJ, Dosoretz DE, Moran BJ, Katin MJ, Braccioforte MH, Ross R, Salenius SA, Kantoff PW, D'Amico AV.Risk of All-Cause and Prostate Cancer-Specific Mortality After Brachytherapy in Men
20605366
Nguyen PL, Chen MH, Beard CJ, Suh WW, Choueiri TK, Efstathiou JA, Hoffman KE, Loffredo M, Kantoff PW, D'Amico AV.Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antige
19957321
Lin NU, Kasparian E, Morganstern DE, Beard C.Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap.J Clin Oncol. 2009 Dec 1;27(34):e218-9.
19786662
Hoffman KE,Chen MH,Punglia RS,Beard CJ,D'Amico AV.Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma.J Clin Oncol. 2008 Aug 20;26(24):3937-42.
18711182
Sommers BD,Beard CJ,D'Amico AV,Kaplan I,Richie JP,Zeckhauser RJ.Predictors of patient preferences and treatment choices for localized prostate cancer.Cancer. 2008 Oct 15;113(8):2058-67.
18704993
Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R.Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.Cell. 2008 Apr 18;1
18423197
Albert M, Song JS, Schultz D, Cormack RA, Tempany CM, Haker S, Devlin PM, Beard C, Hurwitz MD, Suh WW, Jolesz F, D'Amico AV.Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate.Urol Oncol. 2008 Mar-Apr;26(2):
18312933
Sommers BD, Beard CJ, D'Amico AV, Dahl D, Kaplan I, Richie JP, Zeckhauser RJ.Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.Cancer. 2007 Nov 15;110(10):2210-7.
17893907
Pomerantz M, Manola J, Taplin ME, Bubley G, Inman M, Lowell J, Beard C, Kantoff PW, Oh WK.Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer.J Urol. 2007 Jun;177(6):2146-50.
17509304
Nakabayashi M, Beard C, Kelly SM, Carr-Locke DL, Oh WK.Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer.Urol Oncol. 2006 Nov-Dec;24(6):503-8.
17138131
Beard C, Schultz D, Loffredo M, Cote K, Renshaw AA, Hurwitz MD, D'Amico AV.Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer.Int J Radi
16765530
D'Amico AV, Manola J, McMahon E, Loffredo M, Lopes L, Ching J, Albert M, Hurwitz M, Suh WW, Vivenzio TA, Beard C.A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloo
16584760
Beard C, Chen MH, Cote K, Loffredo M, Renshaw A, Hurwitz M, D'Amico AV.Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer.Urology. 2005
16286116
Tsai HK, Manola J, Abner A, Talcott JA, D'Amico AV, Beard C.Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy.Urol O
16018937
Beard CJ.The risk of bladder, bowel, and sexual dysfunction after radiation therapy: what the data tell us and how we can use it to counsel our patients.Cancer J. 2005 Mar-Apr;11(2):106-9.
15969984
Woel R, Beard C, Chen MH, Hurwitz M, Loffredo M, McMahon E, Ching J, Lopes L, D'Amico AV.Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for p
15890580
Landis DM, Schultz D, Cormack R, Tempany C, Beard C, Hurwitz M, O'Leary M, Albert M, Valentine K, D'Amico AV.Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiothera
15833521
Letai A, Sorcinelli MD, Beard C, Korsmeyer SJ.Antiapoptotic BCL-2 is required for maintenance of a model leukemia.Cancer Cell. 2004 Sep;6(3):241-9.
15380515
D'Amico AV, Renshaw AA, Cote K, Hurwitz M, Beard C, Loffredo M, Chen MH.Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease.J Clin Oncol. 2004 Sep 15;22
15365069
Beard CJ, Chen MH, Cote K, Loffredo M, Renshaw AA, Hurwitz M, D'Amico AV.Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer.
14697416
Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, Chen RC, O'Leary MP, Kantoff PW, D'Amico AV.Time course and predictors of symptoms after primary prostate cancer therapy.J Clin Oncol. 2003 Nov 1;21(21):3979-86.
14581420
Hurwitz MD, Schnieder L, Manola J, Beard CJ, Kaplan ID, D'Amico AV.Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis.Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1106-10.
12128108
Killoran JH, Baldini EH, Beard CJ, Chin L.A technique for optimization of digitally reconstructed radiographs of the chest in virtual simulation.Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):231-9.
11163520
D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP.Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical
11062371
D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW.Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.JAMA.
10979115
D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN.Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation th
10458230
D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A.Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for c
9749478
D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Loughlin KR, Richie JP, Wein A.Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poo
9738580
Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, D'Amico A, Kaplan I.Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer.Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):257-6
9607338

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Clair J. Beard, MD Publications Nguyen PL, Chen MH, Goldhaber SZ, Martin NE, Beard CJ, Dosoretz DE, Katin MJ, Ross R, Salenius SA, D'Amico AV.Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation 21108457 Nguyen PL, Chen MH, Beard CJ, Suh WW, Renshaw AA, Loffredo M, McMahon E, Kantoff PW, D'Amico AV.Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate- and High-Risk Clinically Localized Prostate Cancer: A Postrandomization 19864082 Nguyen PL, Chen MH, Choueiri TK, Hoffman KE, Hu JC, Martin NE, Beard CJ, Dosoretz DE, Moran BJ, Katin MJ, Braccioforte MH, Ross R, Salenius SA, Kantoff PW, D'Amico AV.Risk of All-Cause and Prostate Cancer-Specific Mortality After Brachytherapy in Men 20605366 Nguyen PL, Chen MH, Beard CJ, Suh WW, Choueiri TK, Efstathiou JA, Hoffman KE, Loffredo M, Kantoff PW, D'Amico AV.Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antige 19957321 Lin NU, Kasparian E, Morganstern DE, Beard C.Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap.J Clin Oncol. 2009 Dec 1;27(34):e218-9. 19786662 Hoffman KE,Chen MH,Punglia RS,Beard CJ,D'Amico AV.Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma.J Clin Oncol. 2008 Aug 20;26(24):3937-42. 18711182 Sommers BD,Beard CJ,D'Amico AV,Kaplan I,Richie JP,Zeckhauser RJ.Predictors of patient preferences and treatment choices for localized prostate cancer.Cancer. 2008 Oct 15;113(8):2058-67. 18704993 Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R.Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.Cell. 2008 Apr 18;1 18423197 Albert M, Song JS, Schultz D, Cormack RA, Tempany CM, Haker S, Devlin PM, Beard C, Hurwitz MD, Suh WW, Jolesz F, D'Amico AV.Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate.Urol Oncol. 2008 Mar-Apr;26(2): 18312933 Sommers BD, Beard CJ, D'Amico AV, Dahl D, Kaplan I, Richie JP, Zeckhauser RJ.Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.Cancer. 2007 Nov 15;110(10):2210-7. 17893907 Pomerantz M, Manola J, Taplin ME, Bubley G, Inman M, Lowell J, Beard C, Kantoff PW, Oh WK.Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer.J Urol. 2007 Jun;177(6):2146-50. 17509304 Nakabayashi M, Beard C, Kelly SM, Carr-Locke DL, Oh WK.Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer.Urol Oncol. 2006 Nov-Dec;24(6):503-8. 17138131 Beard C, Schultz D, Loffredo M, Cote K, Renshaw AA, Hurwitz MD, D'Amico AV.Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer.Int J Radi 16765530 D'Amico AV, Manola J, McMahon E, Loffredo M, Lopes L, Ching J, Albert M, Hurwitz M, Suh WW, Vivenzio TA, Beard C.A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloo 16584760 Beard C, Chen MH, Cote K, Loffredo M, Renshaw A, Hurwitz M, D'Amico AV.Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer.Urology. 2005 16286116 Tsai HK, Manola J, Abner A, Talcott JA, D'Amico AV, Beard C.Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy.Urol O 16018937 Beard CJ.The risk of bladder, bowel, and sexual dysfunction after radiation therapy: what the data tell us and how we can use it to counsel our patients.Cancer J. 2005 Mar-Apr;11(2):106-9. 15969984 Woel R, Beard C, Chen MH, Hurwitz M, Loffredo M, McMahon E, Ching J, Lopes L, D'Amico AV.Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for p 15890580 Landis DM, Schultz D, Cormack R, Tempany C, Beard C, Hurwitz M, O'Leary M, Albert M, Valentine K, D'Amico AV.Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiothera 15833521 Letai A, Sorcinelli MD, Beard C, Korsmeyer SJ.Antiapoptotic BCL-2 is required for maintenance of a model leukemia.Cancer Cell. 2004 Sep;6(3):241-9. 15380515 D'Amico AV, Renshaw AA, Cote K, Hurwitz M, Beard C, Loffredo M, Chen MH.Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease.J Clin Oncol. 2004 Sep 15;22 15365069 Beard CJ, Chen MH, Cote K, Loffredo M, Renshaw AA, Hurwitz M, D'Amico AV.Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. 14697416 Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, Chen RC, O'Leary MP, Kantoff PW, D'Amico AV.Time course and predictors of symptoms after primary prostate cancer therapy.J Clin Oncol. 2003 Nov 1;21(21):3979-86. 14581420 Hurwitz MD, Schnieder L, Manola J, Beard CJ, Kaplan ID, D'Amico AV.Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis.Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1106-10. 12128108 Killoran JH, Baldini EH, Beard CJ, Chin L.A technique for optimization of digitally reconstructed radiographs of the chest in virtual simulation.Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):231-9. 11163520 D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP.Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical 11062371 D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW.Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.JAMA. 10979115 D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN.Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation th 10458230 D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A.Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for c 9749478 D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Loughlin KR, Richie JP, Wein A.Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poo 9738580 Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, D'Amico A, Kaplan I.Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer.Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):257-6 9607338
Site Map Site Feedback Web Privacy Policy